logo
logo

Colossal raised $200M in a Series C funding led by TWG Global to support its scientific breakthroughs on the path to de-extinction.

Colossal raised $200M in a Series C funding led by TWG Global to support its scientific breakthroughs on the path to de-extinction.

01/15/25, 10:17 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgaustin
Money raised
$200 million
Industry
biotechnology
Investors
Twg Global
Colossal has secured $200 million in Series C funding from TWG Global. This investment will aid the company in its numerous scientific advancements aimed at de-extinction.

Company Info

Company
Colossal Biosciences
Location
austin, texas, united states
Additional Info
Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Related People